Recombinant adenovirus of p16INK4a (Ad5:cTNT-INK4a), p16INK4a scrambled shRNA (Ad5:cTNT-INK4a RNAi), and adenovirus of control (Ad5:cTNT-CON) were designed by CMs specific cTNT promoter obtained from GeneChem Company (China). Ad5:cTNT-CON served as an empty control virus for Ad5:cTNT-INK4a and Ad5:cTNT-INK4a RNAi. It was found in previous studies of primary CMs in vitro that we used a multiplicity of infection (MOI) = 50 as a viral titer to transfect CMs 48 hours after performing other relevant experimental assays [17 (link), 21 (link)]. In vivo, 1-day-old neonatal mice underwent AR + intramyocardial injection: Ad5:cTNT-INK4a RNAi (3.0 × 107 PFU/mouse, total volume = 6 μl/mouse) or Ad5-cTNT-CON (3.0 × 107 PFU/mouse, total volume = 6 μl/mouse).
Free full text: Click here